Showing results (1-10 of 179) with videos related to
Sort By:
Pageof 18
Current Opinion in Pharmacology|November 7, 2020
De-escalation of medical therapy in inflammatory bowel diseaseCatarina Frias Gomes, Thomas P Chapman, Jack SatsangiJournal of Crohn'S & Colitis|January 3, 2021
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021Vipin Gupta, Waled Mohsen, Thomas P Chapman, et al.The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.Alimentary Pharmacology & Therapeutics|May 27, 2020
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.Expert Review of Gastroenterology & Hepatology|October 13, 2009
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural historyCharlie W Lees, Jack SatsangiF1000Prime Reports|June 23, 2015
Pathogenesis of Crohn's diseaseRay Boyapati, Jack Satsangi, Gwo-Tzer HoThe Lancet. Rheumatology|July 20, 2024
Arthritis complicating inflammatory bowel disease- the future is nowKaiyang Song, Jack Satsangi, Laura C CoatesExpert Review of Molecular Diagnostics|November 7, 2023
Current and emerging biomarkers for ulcerative colitisJan K Nowak, Rahul Kalla, Jack SatsangiCurrent Opinion in Genetics & Development|June 3, 2004
Molecular genetics of Crohn's diseaseRichard K Russell, Elaine R Nimmo, Jack SatsangiAnnual Review of Genomics and Human Genetics|May 21, 2009
The genetics of Crohn's diseaseJohan Van Limbergen, David C Wilson, Jack SatsangiPageof 18